Accepted: 6 December 2019
First Online: 6 January 2020
: M.P. is the owner of Parmar Cells AB and co-inventor on the US patent application 15/093,927 owned by Biolamina AB, EP17181588 owned by Miltenyi Biotec and PCT/EP2018/062261 owned by New York Stem Cell Foundation. C.H. has received consultancy fees from US WorldMeds, Adamas Pharmaceuticals, Prevail Therapeutics and Mitsubishi Tanabe Pharma America.